Standout Papers

Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 ... 2023 2026 2024121
  1. Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial (2023)
    Brett King, Xingqi Zhang et al. The Lancet

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 51 standout
Sub-graph 1 of 23

Citing Papers

Therapeutic resistance to anti-oestrogen therapy in breast cancer
2023 Standout
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
2023 Standout
3 intermediate papers

Works of Debanjali Mitra being referenced

Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis
2012
Measuring Economic Outcomes of Alcohol Treatment Using the Economic Form 90*
2007
and 1 more

Author Peers

Author Last Decade Papers Cites
Debanjali Mitra 368 375 160 218 80 1.1k
Luís Alberto Magna 503 127 64 122 107 1.3k
A Bartolucci 178 288 99 126 45 1.2k
Hung‐Chih Hsu 192 502 194 123 100 1.2k
Richard A. Oberfield 169 332 41 96 48 1.2k
Christina Kim 280 228 86 142 76 1.3k
Elisabetta Petracci 351 462 269 88 61 1.1k
Beenish Nafees 493 600 98 129 32 1.2k
Laura Merlini 167 180 84 151 81 1.2k
Kumiko Karasawa 499 309 186 128 122 1.2k
Seyed Ziaeddin Tabei 284 142 55 206 65 1.1k

All Works

Loading papers...

Rankless by CCL
2026